What laboratory workup is recommended for evaluating hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Workup for Hair Loss

In all patients with hair loss, mandatory androgen assessment should be performed, with optional but recommended testing for vitamin D, iron studies, zinc, thyroid hormones, and prolactin 1.

Mandatory Testing

Androgen Assessment

All patients with female pattern hair loss (FPHL) require evaluation for androgen excess 1:

  • Total testosterone using high-quality assay:

    • Preferably liquid chromatography/mass spectrometry (LC/MS)
    • Alternative: immunoassay with sample extraction and purification
    • Avoid standard immunoassays without extraction due to unreliability 1
  • Free testosterone measured by:

    • Equilibrium dialysis (gold standard)
    • Ultracentrifugation
    • Ammonium sulfate precipitation
    • Estimated using SHBG if direct measurement unavailable 1

Important caveat: Isolated FPHL with normal androgen levels should NOT be considered a sign of hyperandrogenism 1. Many patients with FPHL show no hormonal abnormalities despite symptoms 2.

Optional but Recommended Testing

The following tests help rule out conditions that may impair hair regrowth 1:

Iron Studies

  • Serum ferritin is the key marker
  • Evidence remains uncertain regarding the relationship between iron deficiency and FPHL 1
  • No well-controlled studies demonstrate that correcting iron deficiency improves FPHL 1
  • Despite this, testing is recommended to identify and treat deficiency

Vitamin D

  • 25-hydroxyvitamin D levels
  • Studies show 62% of FPHL patients have low vitamin D 1
  • Relationship to hair loss requires further study

Zinc

  • Mean zinc levels are lower in women with FPHL versus controls 1
  • Approximately 15% of FPHL patients present with low zinc 1

Thyroid Function

  • Thyroid profile (TSH at minimum)
  • Rules out thyroid dysfunction affecting hair growth

Prolactin

  • Elevated prolactin can contribute to hair loss
  • Part of comprehensive endocrine evaluation

When Additional Testing is Needed

Complete blood count, ferritin, TSH, and vitamin D should be ordered in all patients with hair loss 3.

Additional testing depends on clinical presentation:

  • Fungal culture if tinea capitis suspected
  • Skin biopsy when diagnosis uncertain or scarring alopecia suspected 1, 3
  • Lupus serology if systemic lupus erythematosus considered
  • Syphilis serology in appropriate clinical context

Key Clinical Pitfalls

  1. Don't over-interpret normal androgens: Sex hormone concentrations often don't correlate with clinical symptoms of hyperandrogenism in FPHL patients 2

  2. Diagnosis is primarily clinical: Laboratory workup supplements but doesn't replace careful history and physical examination 1

  3. Avoid routine autoimmune screening: The increased frequency of autoimmune disease in alopecia areata patients is insufficient to justify routine screening 4

  4. Iron replacement without proven deficiency: No published studies demonstrate treatment response to iron replacement therapy in the absence of documented deficiency 4

References

Research

Is hormone testing worthwhile in patients with female pattern hair loss?

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2020

Research

How to diagnose hair loss.

Dermatologic clinics, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.